Enavate Sciences GP »

Bridgebio Oncology Therapeut shares owned by Enavate Sciences GP

Quarter-by-quarter ownership of Bridgebio Oncology Therapeut shares owned by Enavate Sciences GP from 13F filings

Historical chart of Enavate Sciences GP investment in Bridgebio Oncology Therapeut

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Oncology Therapeut held by Enavate Sciences GP consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Oncology Therapeut by Enavate Sciences GP

Quarter filed Position value Share count Share price at filing
2025-09-30 $30M 2.6M 11.58

More positions owned by Enavate Sciences GP

Zenas Biopharma (ZBIO)
Sionna Therapeutics (SION)
Immunome (IMNM)
Upstream Bio (UPB)
Bridgebio Oncology Therapeut Com New
Compass Therapeutics (CMPX)
Camp4 Therapeutics Corp (CAMP)

View all positions for Enavate Sciences GP

Top funds holding Bridgebio Oncology Therapeut

Cormorant Asset Management
Deerfield Management Company
Omega Fund Management
Wellington Management Company
Alphabet
EcoR1 Capital
Enavate Sciences GP
Citadel Advisors
BlackRock
Novo A/S
Paradigm Biocapital Advisors
Adage Capital Partners GP
Eventide Asset Management
Laurion Capital Management
Octagon Capital Advisors

View all funds holding Bridgebio Oncology Therapeut